Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Rutkowski

Showing results (201-210 of 491) with videos related to

Pageof 50
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 23, 2018
Surgical management of metastatic gastrointestinal stromal tumourYvonne Schrage, Henk Hartgrink, Myles Smith, et al.
Annals of Surgical Oncology|July 8, 2010
Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burdenPiotr Rutkowski, Zbigniew I Nowecki, Alexander C J van Akkooi, et al.
Virchows Archiv : an International Journal of Pathology|December 8, 2023
SATB2, CKAE1/AE3, and synaptophysin as a sensitive immunohistochemical panel for the detection of lymph node metastases of Merkel cell carcinomaAnna Szumera-Cieckiewicz, Daniela Massi, Angelo Cassisa, et al.
International Journal of Molecular Sciences|January 21, 2022
Diagnostic Utility of Genetic and Immunohistochemical <i>H3-3A</i> Mutation Analysis in Giant Cell Tumour of BoneMichał Wągrodzki, Andrzej Tysarowski, Katarzyna Seliga, et al.
Pathology, Research and Practice|July 29, 2021
The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfallOlga Kuczkiewicz-Siemion, Piotr Wiśniewski, Agnieszka Dansonka-Mieszkowska, et al.
International Journal of Clinical Oncology|July 27, 2020
The clinical prognostic factors and treatment outcomes of adult patients with Ewing sarcomaPaulina Jagodzińska-Mucha, Iwona Ługowska, Tomasz Świtaj, et al.
Journal of Clinical Medicine|October 1, 2020
The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial SarcomaKatarzyna Kozak, Paweł Teterycz, Tomasz Świtaj, et al.
Surgical Oncology|September 19, 2020
Malignant peripheral nerve sheath tumors - Outcomes and prognostic factors based on the reference center experiencePaweł Sobczuk, Paweł Teterycz, Anna M Czarnecka, et al.
The Oncologist|August 8, 2018
Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell ChondrosarcomaAnnemiek van Maldegem, Anthony P Conley, Piotr Rutkowski, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2024
Open-label, phase II study of talimogene laherparepvec plus pembrolizumab for the treatment of advanced melanoma that progressed on prior anti-PD-1 therapy: MASTERKEY-115Caroline Robert, Brian Gastman, Helen Gogas, et al.
Pageof 50

Showing results (201-210 of 491) with videos related to

Sort By:
Pageof 50
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 23, 2018
Surgical management of metastatic gastrointestinal stromal tumourYvonne Schrage, Henk Hartgrink, Myles Smith, et al.
Annals of Surgical Oncology|July 8, 2010
Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burdenPiotr Rutkowski, Zbigniew I Nowecki, Alexander C J van Akkooi, et al.
Virchows Archiv : an International Journal of Pathology|December 8, 2023
SATB2, CKAE1/AE3, and synaptophysin as a sensitive immunohistochemical panel for the detection of lymph node metastases of Merkel cell carcinomaAnna Szumera-Cieckiewicz, Daniela Massi, Angelo Cassisa, et al.
International Journal of Molecular Sciences|January 21, 2022
Diagnostic Utility of Genetic and Immunohistochemical <i>H3-3A</i> Mutation Analysis in Giant Cell Tumour of BoneMichał Wągrodzki, Andrzej Tysarowski, Katarzyna Seliga, et al.
Pathology, Research and Practice|July 29, 2021
The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfallOlga Kuczkiewicz-Siemion, Piotr Wiśniewski, Agnieszka Dansonka-Mieszkowska, et al.
International Journal of Clinical Oncology|July 27, 2020
The clinical prognostic factors and treatment outcomes of adult patients with Ewing sarcomaPaulina Jagodzińska-Mucha, Iwona Ługowska, Tomasz Świtaj, et al.
Journal of Clinical Medicine|October 1, 2020
The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial SarcomaKatarzyna Kozak, Paweł Teterycz, Tomasz Świtaj, et al.
Surgical Oncology|September 19, 2020
Malignant peripheral nerve sheath tumors - Outcomes and prognostic factors based on the reference center experiencePaweł Sobczuk, Paweł Teterycz, Anna M Czarnecka, et al.
The Oncologist|August 8, 2018
Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell ChondrosarcomaAnnemiek van Maldegem, Anthony P Conley, Piotr Rutkowski, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2024
Open-label, phase II study of talimogene laherparepvec plus pembrolizumab for the treatment of advanced melanoma that progressed on prior anti-PD-1 therapy: MASTERKEY-115Caroline Robert, Brian Gastman, Helen Gogas, et al.
Pageof 50